The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1185
June 21, 2004
View Complete Issue         Table of Contents 2019 
Conductive Keratoplasty (CK) for Presbyopia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Conductive Keratoplasty (CK) for Presbyopia
June 21, 2004 (Issue: 1185)
The ViewPoint CK System (Refractec) for conductive keratoplasty (CK), previously approved by the FDA as a device for treatment of hyperopia (farsightedness), was recently approved for treatment of presbyopia (age-associated loss of ability to view...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Conductive Keratoplasty (CK) for Presbyopia
Article code: 1185a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.